MassDevice.com gathered a group of executives from 3M (NYSE:MMM), CVRx and St. Jude Medical (NYSE:STJ) on June 24 in St. Paul, Minn., to discuss the current climate of the medical technology industry following the massive $43 billion merger of Medtronic (NYSE:MDT) and Covidien (NYSE:COV).
The podcast, taped live at our DeviceTalks Minnesota event, can be found below in its entirety.
Like what you hear? Join us July 15 in Boston for a chance to see DeviceTalks live
The panel featured Deb Rectenwald, president & general manager of 3M’s infection prevention unit; Nadim Yared, CEO of CVRx; and St. Jude’s senior vice president of R&D Philip Ebeling.
Click here for part 1 of this podcast, featuring Covidien’s Stacy Enxing Seng.